New Drugs and Targets for Asthma & COPD
Imperial College London / National Heart & Lung Institute
Archivio
25.11.2009 - 27.11.2009 London
Contenuti (corsi)
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
Pubblico target
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
Informazioni ed Iscrizioni:
Ms. Karina Dixon
Medicina interna, Ricerca clinica, Terapia Intensiva
Lingua
Inglese
Inglese
Costi
GBP 650,00
GBP 650,00
Contatto organizzatori
Dovehouse Street
SW3 6LY London
United Kingdom
Dovehouse Street
SW3 6LY London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
